Source link : https://newshealth.biz/health-news/first-gene-therapy-approved-for-hearing-loss/
The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the agency announced on Thursday. An adeno-associated virus vector-based gene therapy, lunsotogene parvec is indicated for pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss (any frequency >90 decibel hearing level [dB HL]) associated with […]
The post First Gene Therapy Approved for Hearing Loss first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-23 21:17:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8